Variant report

Variant	nsv874035
Chromosome Location	chr2:50877042-50947044
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:219)
CpG islands
(count:122)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:219 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr2:50919262-50919518	K562	blood:	n/a	chr2:50919400-50919413 chr2:50919400-50919411
2	CEBPB	chr2:50919242-50919552	HepG2	liver:	n/a	chr2:50919400-50919413 chr2:50919400-50919411
3	CEBPB	chr2:50919241-50919557	IMR90	lung:	n/a	chr2:50919400-50919413 chr2:50919400-50919411
4	CEBPB	chr2:50890728-50891191	HepG2	liver:	n/a	chr2:50890749-50890760 chr2:50891044-50891055
5	CTCF	chr2:50902100-50902250	BE2_C	brain:	n/a	n/a
6	CTCF	chr2:50902100-50902250	HCPEpiC	choroid plexus:	n/a	n/a
7	CTCF	chr2:50902173-50902283	HepG2	liver:	n/a	n/a
8	CTCF	chr2:50889605-50889670	MCF-7	breast:	n/a	n/a
9	CTCF	chr2:50902140-50902290	GM12873	blood:	n/a	n/a
10	CTCF	chr2:50902100-50902250	GM12870	blood:	n/a	n/a
11	CTCF	chr2:50901960-50902110	RPTEC	kidney:	n/a	n/a
12	CTCF	chr2:50902140-50902290	HRPEpiC	eye:	n/a	n/a
13	CTCF	chr2:50902120-50902270	K562	blood:	n/a	n/a
14	CTCF	chr2:50902176-50902276	GM10248	blood:	n/a	n/a
15	CTCF	chr2:50902180-50902330	GM12878	blood:	n/a	n/a
16	CTCF	chr2:50902180-50902330	GM12871	blood:	n/a	n/a
17	CTCF	chr2:50902155-50902284	GM13977	blood:	n/a	n/a
18	CTCF	chr2:50902140-50902290	GM12865	blood:	n/a	n/a
19	CTCF	chr2:50902200-50902350	HRE	kidney:	n/a	n/a
20	CTCF	chr2:50902100-50902250	HFF-Myc	foreskin:	n/a	n/a
21	CTCF	chr2:50889585-50889672	MCF-7	breast:	n/a	n/a
22	CTCF	chr2:50902154-50902311	Hela-S3	cervix:	n/a	n/a
23	CTCF	chr2:50889603-50889665	GM19240	blood:	n/a	n/a
24	CTCF	chr2:50902120-50902270	GM12867	blood:	n/a	n/a
25	CTCF	chr2:50889598-50889668	NHEK	skin:	n/a	n/a
26	CTCF	chr2:50902120-50902270	GM12866	blood:	n/a	n/a
27	CTCF	chr2:50902100-50902250	HepG2	liver:	n/a	n/a
28	CTCF	chr2:50902128-50902354	IMR90	lung:	n/a	n/a
29	CTCF	chr2:50902182-50902235	LNCaP	prostate:	n/a	n/a
30	CTCF	chr2:50902220-50902370	A549	lung:	n/a	n/a
31	CTCF	chr2:50902140-50902290	NB4	blood:	n/a	n/a
32	CTCF	chr2:50902180-50902330	HA-sp	spinal cord:	n/a	n/a
33	CTCF	chr2:50902120-50902270	GM12874	blood:	n/a	n/a
34	CTCF	chr2:50902161-50902296	GM10266	blood:	n/a	n/a
35	CTCF	chr2:50902140-50902290	WERI-Rb-1	eye:	n/a	n/a
36	CTCF	chr2:50889589-50889673	MCF-7	breast:	n/a	n/a
37	CTCF	chr2:50902120-50902270	HMEC	breast:	n/a	n/a
38	CTCF	chr2:50902100-50902250	AG04449	skin:	n/a	n/a
39	CTCF	chr2:50907104-50907160	GM20000	blood:	n/a	n/a
40	CTCF	chr2:50902100-50902250	NHEK	skin:	n/a	n/a
41	CTCF	chr2:50902138-50902315	NHEK	skin:	n/a	n/a
42	CTCF	chr2:50902200-50902350	HCFaa	heart:	n/a	n/a
43	CTCF	chr2:50902100-50902250	HCT-116	colon:	n/a	n/a
44	CTCF	chr2:50902100-50902250	GM12864	blood:	n/a	n/a
45	CTCF	chr2:50902155-50902320	GM12878	blood:	n/a	n/a
46	CTCF	chr2:50886104-50886220	NHEK	skin:	n/a	n/a
47	CTCF	chr2:50889588-50889678	GM19239	blood:	n/a	n/a
48	CTCF	chr2:50926700-50926850	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr2:50902080-50902230	HL-60	blood:	n/a	n/a
50	CTCF	chr2:50902100-50902250	Hela-S3	cervix:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:50884693-50884743	AG09309	skin:	n/a
2	chr2:50884693-50884743	SK-N-MC	brain:	n/a
3	chr2:50884252-50884302	NHBE	bronchial:	n/a
4	chr2:50884252-50884302	NHDF-neo	bronchial:	n/a
5	chr2:50884693-50884743	HRCEpiC	kidney:	n/a
6	chr2:50884252-50884302	AG10803	skin:	n/a
7	chr2:50884252-50884302	PFSK-1	brain:	n/a
8	chr2:50884252-50884302	HCPEpiC	choroid plexus:	n/a
9	chr2:50884252-50884302	ovcar-3	ovarian:	n/a
10	chr2:50884693-50884743	NH-A	brain:	n/a
11	chr2:50884693-50884743	HNPCEpiC	eye:	n/a
12	chr2:50884693-50884743	SAEC	small airway:	n/a
13	chr2:50884252-50884302	NT2-D1	testis:	n/a
14	chr2:50884693-50884743	GM06990	blood:	n/a
15	chr2:50884252-50884302	Caco-2	colon:	n/a
16	chr2:50884693-50884743	ovcar-3	ovarian:	n/a
17	chr2:50884693-50884743	HRE	kidney:	n/a
18	chr2:50884252-50884302	AG09319	gingival:	n/a
19	chr2:50884693-50884743	NT2-D1	testis:	n/a
20	chr2:50884693-50884743	RPTEC	kidney:	n/a
21	chr2:50884252-50884302	Hepatocyte	liver:	n/a
22	chr2:50884693-50884743	AG10803	skin:	n/a
23	chr2:50884693-50884743	MCF10A-Er-Src	breast:	n/a
24	chr2:50884693-50884743	AG09319	gingival:	n/a
25	chr2:50884693-50884743	SK-N-SH_RA	brain:	n/a
26	chr2:50884693-50884743	H1-hESC	embryonic stem cell:	embryo
27	chr2:50884693-50884743	HCPEpiC	choroid plexus:	n/a
28	chr2:50884693-50884743	U87	brain:	n/a
29	chr2:50884252-50884302	HAEpiC	amniotic membrane:	n/a
30	chr2:50884252-50884302	HPAEpiC	pulmonary alveolar:	n/a
31	chr2:50884252-50884302	NB4	blood:	n/a
32	chr2:50884693-50884743	GM12892	blood:	n/a
33	chr2:50884693-50884743	NHDF-neo	bronchial:	n/a
34	chr2:50884252-50884302	HCF	heart:	n/a
35	chr2:50884693-50884743	PrEC	prostate:	n/a
36	chr2:50884693-50884743	ProgFib	skin:	n/a
37	chr2:50884693-50884743	AG04449	skin:	fetal
38	chr2:50884252-50884302	GM19239	blood:	n/a
39	chr2:50884693-50884743	Hepatocyte	liver:	n/a
40	chr2:50884693-50884743	HEK293	kidney:	embryo
41	chr2:50884693-50884743	HRPEpiC	eye:	n/a
42	chr2:50884252-50884302	HCM	heart:	n/a
43	chr2:50884693-50884743	BJ	skin:	n/a
44	chr2:50884252-50884302	A549	lung:	n/a
45	chr2:50884693-50884743	K562	blood:	n/a
46	chr2:50884693-50884743	LNCaP	prostate:	n/a
47	chr2:50884693-50884743	HAEpiC	amniotic membrane:	n/a
48	chr2:50884252-50884302	LNCaP	prostate:	n/a
49	chr2:50884252-50884302	SK-N-SH_RA	brain:	n/a
50	chr2:50884252-50884302	IMR90	lung:	fetal

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:50884111..50885778-chr2:50886770..50888521,2	MCF-7	breast:
2	chr2:50884111..50885778-chr2:50886770..50888521,2	MCF-7	breast:
3	chr2:50946676..50947176-chr20:60981159..60981778,2	MCF-7	breast:
4	chr2:50909775..50912434-chr2:50920496..50923402,2	MCF-7	breast:
5	chr2:50884335..50886694-chr2:50887318..50889235,3	K562	blood:
6	chr2:50883231..50884999-chr2:50887642..50889397,2	MCF-7	breast:
7	chr2:50884335..50886694-chr2:50887318..50889235,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000216191	TF binding region
NRXN1	TF binding region
ENSG00000216191	CpG island
NRXN1	CpG island
ENSG00000216191	chromatin interactions
ENSG00000179915	chromatin interactions

Extended variants
information (count: 2487 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:2487 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs858953	chr2:50877042-50877043	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs565246144	chr2:50877054-50877055	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs532878752	chr2:50877065-50877066	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs548064800	chr2:50877074-50877075	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs182714297	chr2:50877080-50877081	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs533028133	chr2:50877087-50877088	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs546750329	chr2:50877106-50877107	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs187833706	chr2:50877122-50877123	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs548028907	chr2:50877163-50877164	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs569714309	chr2:50877225-50877226	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs858954	chr2:50877233-50877234	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs558150207	chr2:50877361-50877362	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs78494737	chr2:50877391-50877392	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs858955	chr2:50877396-50877397	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs552622100	chr2:50877402-50877403	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs552836704	chr2:50877441-50877442	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs190287617	chr2:50877450-50877451	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs111786997	chr2:50877461-50877462	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs541986274	chr2:50877473-50877474	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs561259289	chr2:50877491-50877492	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs139202665	chr2:50877500-50877501	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs145276700	chr2:50877506-50877507	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs147639663	chr2:50877525-50877526	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs182369654	chr2:50877568-50877569	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs187403266	chr2:50877598-50877599	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs140758482	chr2:50877600-50877601	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs530262421	chr2:50877602-50877603	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs548750284	chr2:50877610-50877611	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs61062807	chr2:50877617-50877618	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs536750570	chr2:50877628-50877629	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs551812951	chr2:50877644-50877645	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs570152289	chr2:50877653-50877654	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs77120145	chr2:50877689-50877690	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs11893056	chr2:50877702-50877703	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs191941798	chr2:50877704-50877705	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs145778229	chr2:50877741-50877742	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs535352388	chr2:50877762-50877763	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs75066615	chr2:50877763-50877764	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs575300026	chr2:50877827-50877828	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs201543172	chr2:50877828-50877829	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs565371149	chr2:50877834-50877835	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs577359689	chr2:50877847-50877848	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs541417998	chr2:50877851-50877852	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs559832520	chr2:50877899-50877900	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs368193893	chr2:50877910-50877911	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs530441192	chr2:50877922-50877923	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs542108158	chr2:50877951-50877952	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs185763832	chr2:50877965-50877966	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs370602799	chr2:50877978-50877979	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs530998235	chr2:50877988-50877989	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Basal cell lymphoma	21115979	CNVD
Cognitive impairment	21505072	CNVD
Psychiatric disorder	19734545	CNVD
Autism	20844286	CNVD
Schizophrenia	20838587	CNVD
Schizophrenia	20718829	CNVD
Autism	19218893	CNVD
Autism	22209245	CNVD
Neuropsychiatric disorder	21827697	CNVD
Schizophrenia	22118685	CNVD
Autism	20663923	CNVD
Schizophrenia	21285140	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21990379	CNVD
Schizophrenia	22885689	CNVD
Autism	20964600	CNVD
Schizophrenia	19521646	CNVD
Attention deficit hyperactivity disorder	22214315	CNVD
Chronic motor tic disorder	22214315	CNVD
Schizophrenia	22214315	CNVD
Mental retardation	19896112	CNVD
Acute myeloid leukemia	20729466	CNVD
Bipolar disorder	19114987	CNVD
Autism	20841430	CNVD

Chromatin state (count:224 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:50872200-50877800	Enhancers	Fetal Brain Male	brain
2	chr2:50874800-50878000	Enhancers	HUES48 Cell Line	embryonic stem cell
3	chr2:50875400-50877800	Enhancers	iPS-20b Cell Line	embryonic stem cell
4	chr2:50875600-50878000	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr2:50875800-50877600	Enhancers	HSMMtube	muscle
6	chr2:50875800-50878000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr2:50876000-50878800	Weak transcription	Brain Hippocampus Middle	brain
8	chr2:50876000-50878800	Weak transcription	Brain Substantia Nigra	brain
9	chr2:50876000-50878800	Weak transcription	Fetal Brain Female	brain
10	chr2:50876200-50879200	Weak transcription	Brain Cingulate Gyrus	brain
11	chr2:50876400-50878200	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr2:50876400-50879800	Enhancers	HMEC	breast
13	chr2:50876600-50877200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr2:50876600-50877600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr2:50876600-50877800	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr2:50876600-50877800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr2:50876800-50877400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr2:50876800-50877400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr2:50876800-50878000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr2:50876800-50878000	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr2:50877000-50877400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr2:50877000-50877800	Enhancers	H1 Cell Line	embryonic stem cell
23	chr2:50877000-50877800	Enhancers	H9 Cell Line	embryonic stem cell
24	chr2:50877000-50877800	Enhancers	Cortex derived primary cultured neurospheres	brain
25	chr2:50877000-50878000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr2:50877000-50878000	Flanking Active TSS	NHEK	skin
27	chr2:50877000-50879200	Enhancers	Brain Germinal Matrix	brain
28	chr2:50877200-50877400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr2:50877200-50877800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
30	chr2:50877200-50877800	Enhancers	NH-A	brain
31	chr2:50877400-50877600	Enhancers	Fetal Kidney	kidney
32	chr2:50877400-50877800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr2:50877400-50879000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr2:50877600-50879000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr2:50877800-50878200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr2:50877800-50878800	Weak transcription	Cortex derived primary cultured neurospheres	brain
37	chr2:50878000-50879000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
38	chr2:50878000-50879400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr2:50878000-50879800	Enhancers	NHEK	skin
40	chr2:50878200-50878800	Weak transcription	HUES64 Cell Line	embryonic stem cell
41	chr2:50878200-50880000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
42	chr2:50878600-50879200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
43	chr2:50878800-50879000	Enhancers	HUES64 Cell Line	embryonic stem cell
44	chr2:50878800-50879000	Enhancers	Brain Substantia Nigra	brain
45	chr2:50878800-50879400	Enhancers	Brain Hippocampus Middle	brain
46	chr2:50878800-50879400	Enhancers	Fetal Brain Female	brain
47	chr2:50878800-50879800	Enhancers	Cortex derived primary cultured neurospheres	brain
48	chr2:50879000-50879200	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr2:50879000-50879400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
50	chr2:50879000-50879400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links